Stryker Corporation
SYK
Rang in aandelen
#190
Stryker Corporation functions as a prominent medical technology enterprise,... Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.
Aandeelprijs
$304.72
Laatst gesynchroniseerd: 2026-10-20
Marktkapitalisatie
$116.88B
Verandering (1 dag)
1.96%
Verandering (1 jaar)
-19.76%
Land
US
Handel Stryker Corporation (SYK)
Categorie
Healthcare
Winst voor Stryker Corporation (SYK)
Winst in Jun 2026 TTM: $5.15B
Volgens de meest recente financiële verslagen van Stryker Corporation bedraagt de huidige winst van het bedrijf $5.15B. In 2024 behaalde het bedrijf een winst van $3.49B, een daling ten opzichte van de winst van 2023, die $3.67B bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Stryker Corporation van 2000 tot 2026
Winst aan het einde van elk jaar
| Jaar | Winst | Wijzigen |
|---|---|---|
| 2026 (TTM) | $5.15B | 14.05% |
| 2025 | $4.51B | 29.27% |
| 2024 | $3.49B | -4.93% |
| 2023 | $3.67B | 36.90% |
| 2022 | $2.68B | 17.62% |
| 2021 | $2.28B | 16.73% |
| 2020 | $1.95B | -23.73% |
| 2019 | $2.56B | 8.74% |
| 2018 | $2.36B | 14.20% |
| 2017 | $2.06B | 7.39% |
| 2016 | $1.92B | 10.72% |
| 2015 | $1.74B | 49.57% |
| 2014 | $1.16B | -4.29% |
| 2013 | $1.21B | -28.91% |
| 2012 | $1.71B | 1.13% |
| 2011 | $1.69B | -2.52% |
| 2010 | $1.73B | 6.51% |
| 2009 | $1.62B | 2.77% |
| 2008 | $1.58B | 15.33% |
| 2007 | $1.37B | 24.13% |
| 2006 | $1.10B | 10.02% |
| 2005 | $1.00B | 39.93% |
| 2004 | $717.00M | 9.89% |
| 2003 | $652.50M | 28.77% |
| 2002 | $506.70M | 24.90% |
| 2001 | $405.70M | 21.14% |
| 2000 | $334.90M | 0.00% |
Winst van vergelijkbare bedrijven of concurrenten
| Bedrijf | Winst | Winstverschil | Land |
|---|---|---|---|
| $7.51B | 45.90% |
US
|
|
| $5.56B | 8.06% |
IE
|
|
| $3.86B | -25.00% |
US
|
|
| - | - |
DE
|
|
| $1.42B | -72.46% |
US
|
